Vascular endothelial growth factor (VEGF) monoclonal antibody (mAb) was conjugated to liposomes encapsulating paclitaxel, which selectively guided the delivery and accumulation in the VEGF-overexpressing tumor and release the chemotherapeutic agent within the tumor (Shi et al., 2015). Here, VEGFA is linked to neoplasm.